156 related articles for article (PubMed ID: 32561364)
21. Epidemiology of Renal Cell Carcinoma.
Capitanio U; Bensalah K; Bex A; Boorjian SA; Bray F; Coleman J; Gore JL; Sun M; Wood C; Russo P
Eur Urol; 2019 Jan; 75(1):74-84. PubMed ID: 30243799
[TBL] [Abstract][Full Text] [Related]
22. Genitourinary tumor following kidney transplantation: a multicenter study.
Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
[TBL] [Abstract][Full Text] [Related]
23. Risk of subsequent cancers in renal cell carcinoma survivors with a family history.
Chen T; Fallah M; Sundquist K; Liu H; Hemminki K
Eur J Cancer; 2014 Aug; 50(12):2108-18. PubMed ID: 24923229
[TBL] [Abstract][Full Text] [Related]
24. Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden.
Wilson RT; Donahue M; Gridley G; Adami J; El Ghormli L; Dosemeci M
Am J Ind Med; 2008 Feb; 51(2):83-99. PubMed ID: 18067176
[TBL] [Abstract][Full Text] [Related]
25. Review of potential risk factors for kidney (renal cell) cancer.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):280-93. PubMed ID: 11769880
[TBL] [Abstract][Full Text] [Related]
26. Observations on the effect of abolishing analgesic abuse and reducing smoking on cancers of the kidney and bladder in New South Wales, Australia, 1972-1995.
McCredie M; Stewart J; Smith D; Supramaniam R; Williams S
Cancer Causes Control; 1999 Aug; 10(4):303-11. PubMed ID: 10482489
[TBL] [Abstract][Full Text] [Related]
27. [Renal cell carcinoma in the department of Hérault: Results over a 30 year period].
Hutin M; Trétarre B; Gras C; Bessaoud F; Daurès JP; Delbos O; Bringer JP; Ayuso D; Thuret R; Azria D; Serre I; Brel D; Reis Borges R; Iborra F; Rébillard X;
Prog Urol; 2021 Mar; 31(3):175-182. PubMed ID: 33160850
[TBL] [Abstract][Full Text] [Related]
28. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
29. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?
Henning A; Wehrberger M; Madersbacher S; Pycha A; Martini T; Comploj E; Jeschke K; Tripolt C; Rauchenwald M
BJU Int; 2013 Jul; 112(1):68-73. PubMed ID: 23320798
[TBL] [Abstract][Full Text] [Related]
30. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
Liu H; Sundquist J; Hemminki K
Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
[TBL] [Abstract][Full Text] [Related]
31. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
Kim DY; Abouljoud M; Parasuraman R
Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
[TBL] [Abstract][Full Text] [Related]
32. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
33. Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment.
Wauters L; Billiet T; Papamichael K; Ballet V; Joniau S; Verschueren P; Silversmit G; Van Assche G; Vermeire S; Ferrante M
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):84-90. PubMed ID: 27603297
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
[TBL] [Abstract][Full Text] [Related]
35. Second primary malignancies associated with renal cell carcinoma: influence of histologic type.
Rabbani F; Reuter VE; Katz J; Russo P
Urology; 2000 Sep; 56(3):399-403. PubMed ID: 10962302
[TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
37. Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study.
Theis RP; Dolwick Grieb SM; Burr D; Siddiqui T; Asal NR
BMC Cancer; 2008 Dec; 8():387. PubMed ID: 19108730
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
39. Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979 - 2001.
Lyrdal D; Aldenborg F; Holmberg E; Peeker R; Lundstam S
Scand J Urol; 2013 Aug; 47(4):302-10. PubMed ID: 23137102
[TBL] [Abstract][Full Text] [Related]
40. Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study.
Singleton RK; Heath AK; Clasen JL; Scelo G; Johansson M; Calvez-Kelm FL; Weiderpass E; Liedberg F; Ljungberg B; Harbs J; Olsen A; Tjønneland A; Dahm CC; Kaaks R; Fortner RT; Panico S; Tagliabue G; Masala G; Tumino R; Ricceri F; Gram IT; Santiuste C; Bonet C; Rodriguez-Barranco M; Schulze MB; Bergmann MM; Travis RC; Tzoulaki I; Riboli E; Muller DC
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):507-512. PubMed ID: 33335022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]